Published in Endocrinology on January 01, 1983
Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest (1993) 1.22
Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol (2011) 0.97
The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure. Hypertension (2013) 0.96
Reno-endocrinal disorders: A basic understanding of the molecular genetics. Indian J Endocrinol Metab (2012) 0.90
Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease. Am J Physiol Regul Integr Comp Physiol (2011) 0.80
Retracted Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats. Br J Pharmacol (2002) 0.79
Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs. J Clin Invest (1984) 0.77
Effects of interrupting the renin-angiotensin system on sodium excretion in man. J Physiol (1988) 0.75
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev (1977) 3.70
The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest (1996) 2.46
Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension (1982) 2.32
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest (1997) 2.05
Elevated intra-abdominal pressure and renal function. Ann Surg (1982) 2.05
Molecular biology of angiotensinogen. Hypertension (1991) 1.97
Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res (1982) 1.79
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension (1997) 1.77
Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem (1992) 1.76
Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem Biophys Res Commun (1998) 1.68
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A (1999) 1.60
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol (1989) 1.55
Recruitment of renin gene-expressing cells in adult rat kidneys. Am J Physiol (1990) 1.50
Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension (1999) 1.50
Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol (1999) 1.48
Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension (1991) 1.48
Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A (1998) 1.45
Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol (1989) 1.45
Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension (1995) 1.42
The changing clinical spectrum of adrenal insufficiency. Ann Intern Med (1997) 1.38
Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res (1989) 1.36
Localization of angiotensinogen messenger RNA in rat aorta. Circ Res (1988) 1.35
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest (1998) 1.34
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
Hypercalcemia associated with chronic lymphocytic leukemia. Arch Intern Med (1979) 1.33
Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension (1999) 1.33
Rapid adrenocorticotropic hormone test in practice. Retrospective review. Am J Med (1985) 1.31
Toxoplasmosis. Clinical experiences in a cancer hospital. Am J Med (1973) 1.29
Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism. J Pharmacol Exp Ther (1983) 1.28
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res (1992) 1.27
Mechanisms of endothelium-dependent vascular smooth muscle relaxation. Biochem Pharmacol (1985) 1.26
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med (1972) 1.23
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension (1992) 1.23
Measurement of the negative muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2004) 1.19
Renin-angiotensin system modulates renal bradykinin production. Am J Physiol (1996) 1.18
Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther (1969) 1.18
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension (2000) 1.17
Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med (1973) 1.16
The Charlottesville blood pressure survey: the role of the physician in hypertension case finding. Med Care (1977) 1.16
The Charlottesville Blood-Pressure Survey. Value of repeated blood-pressure measurements. JAMA (1976) 1.13
Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest (1988) 1.12
Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res (1977) 1.12
Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res (1981) 1.11
Stimulation of release of adrenal catecholamine by adenosine 3':5'-cyclic monophosphate and theophylline in the absence of extracellular Ca 2+ . Proc Natl Acad Sci U S A (1972) 1.11
Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid. J Pharmacol Exp Ther (1983) 1.10
A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med (1975) 1.09
The renal dopamine receptors. J Am Soc Nephrol (1992) 1.09
Control of intestinal absorption by the renin-angiotensin system. Am J Physiol (1985) 1.09
Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am J Physiol (1994) 1.08
Location and regulation of rat angiotensinogen messenger RNA. Hypertension (1988) 1.08
The hepatic angiotensin II receptor. I. Characterization of the membrane-binding site and correlation with physiological response in hepatocytes. J Biol Chem (1982) 1.08
Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension (2000) 1.07
Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ Res (1992) 1.07
Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension (1999) 1.05
In vitro activation of the alternative pathway of complement by settled grain dust. J Allergy Clin Immunol (1978) 1.04
A comparison on natriuresis after oral and intravenous sodium loading in sodium-depleted rabbits: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med (1975) 1.04
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. J Clin Invest (1980) 1.03
Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. N Engl J Med (1984) 1.03
Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension (1997) 1.02
Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol (2001) 1.02
Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone. Circ Res (1978) 1.02
Workplace protection factor measurements on powered air-purifying respirators at a secondary lead smelter: results and discussion. Am Ind Hyg Assoc J (1984) 1.02
Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: morphological analysis of angiotensin II processing in isolated vascular strips. J Vasc Res (1994) 1.02
Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension (1984) 1.02
Granulocytes and phorbol myristate acetate increase permeability to albumin of cultured endothelial monolayers and isolated perfused lungs. Role of oxygen radicals and granulocyte adherence. Am Rev Respir Dis (1983) 1.01
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors. Am J Physiol Renal Physiol (2001) 1.01
Response of rat jejunum to angiotensin II: role of norepinephrine and prostaglandins. Am J Physiol (1981) 1.00
Angiotensinogen gene expression in 3T3-L1 cells. Am J Physiol (1989) 1.00
Angiotensin II regulates renin gene expression. Am J Physiol (1990) 1.00
Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab (1979) 0.99
The renin response to diuretic therapyl A limitation of antihypertensive potential. Circ Res (1978) 0.99
Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells. Regul Pept (1993) 0.99
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest (1979) 0.99
Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens (1996) 0.99
Gastrointestinal control of sodium excretion in sodium-depleted conscious rabbits. Am J Physiol (1976) 0.99
Endothelium-derived vascular relaxing factor. Hypertension (1985) 0.99
Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol (1998) 0.99
Enhancement of the electrically induced release of norepinephrine from the rat portal vein: mediation by beta 2-adrenoceptors. Eur J Pharmacol (1979) 0.98
Evidence for endothelium-derived relaxing factor in cultured cells. Hypertension (1985) 0.98
Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion. Hypertension (1997) 0.98
Molecular actions of angiotensin. Biochem Pharmacol (1981) 0.98
The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man. J Clin Endocrinol Metab (1988) 0.98
Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab (1983) 0.98
Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am J Physiol (1993) 0.97